Affinitätspolypeptide für Vollständige Aav-Kapside
Anmelder: Daicel Corporation, NATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGY 🇯🇵
Details
- Veröffentlichungs-Nr.
- EP4806914
- Anmeldetag
- 5. November 2024
- Veröffentlichung
- 15. Mai 2025
- Rechtsraum
- EP
Abstract
An object of the present disclosure is to provide an affinity molecule having higher binding affinity for AAV full capsids than for AAV empty capsids. An anti-AAV full capsid molecule, which includes a heavy chain variable region including, as heavy chain complementarity-determining regions, CDR1 set forth in SEQ ID NO: 6, CDR2 set forth in SEQ ID NO: 7, and CDR3 set forth in SEQ ID NO: 8; and a light chain variable region including, as light chain complementarity-determining regions, CDR1 set forth in SEQ ID NO: 9, CDR2 consisting of RAS, and CDR3 set forth in SEQ ID NO: 10, has higher binding affinity for AAV full capsids than for AAV empty capsids.
Anmelder
- Firmen
- Daicel Corporation
NATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGY - Land
- 🇯🇵 Japan
Daicel Corporation ist ein japanisches Chemieunternehmen, das Celluloseacetat, Airbag-Gasgeneratoren und Spezialchemikalien herstellt.
1.532 Patente in unserer Datenbank